NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK)
Post# of 121
Grey Cloak Tech (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced an independent corporate analysis prepared by David L. Lavigne, senior analyst and managing partner at Trickle Research specializing in independent microcap research. “We are continually striving to build credibility and confidence within the investment community,” Duke Pitts, president and CEO of Grey Cloak Tech, soon to be Healthy Extracts Inc., said in the news release, “and having an independent analysis research report provides positive insight, with a projected $0.17 price target in 12 to 24 months.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer